Φορτώνει......

Ninety-day Readmission and Long-Term Mortality in Medicare Patients (≥65 Years) Treated With Ticagrelor Versus Prasugrel After Percutaneous Coronary Intervention (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium)

Ticagrelor and prasugrel were found to be superior to clopidogrel for the treatment of acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI); however, the comparative effectiveness of these 2 drugs remains unknown. We compared post-discharge outcomes among older patients treat...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Am J Cardiol
Κύριοι συγγραφείς: Song, Chris, Sukul, Devraj, Seth, Milan, Dupree, James M., Khandelwal, Akshay, Dixon, Simon R., Wohns, David, LaLonde, Thomas, Gurm, Hitinder S.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: 2017
Θέματα:
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850017/
https://ncbi.nlm.nih.gov/pubmed/29025684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2017.08.009
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!